39.06 -1.53 (-3.77%) | 04-05 00:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 46.7 | 1-year : | 47.5 |
Resists | First : | 39.98 | Second : | 40.66 |
Pivot price | 39.06 | |||
Supports | First : | 38.88 | Second : | 32.34 |
MAs | MA(5) : | 39.06 | MA(20) : | 39.06 |
MA(100) : | 39.06 | MA(250) : | 55.37 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 10 | D(3) : | 10 |
RSI | RSI(14): 20.7 | |||
52-week | High : | 84.82 | Low : | 38.88 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CFX ] has closed Bollinger Bands are 0% narrower than normal.
If tomorrow: | Open lower | Open higher |
High: | 40.71 - 40.91 | 40.91 - 41.08 |
Low: | 38.42 - 38.64 | 38.64 - 38.83 |
Close: | 38.73 - 39.07 | 39.07 - 39.37 |
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
Sat, 16 Mar 2024
Colfax's (CFX) Unit Closes Buyout of Trilliant Surgical - Yahoo Movies Canada
Tue, 05 Apr 2022
Colfax Stock: Chapter Ends, ESAB & Enovis Have To Prove (NYSE:CFX) - Seeking Alpha
Mon, 14 Mar 2022
Colfax Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation - Yahoo Finance
Fri, 11 Mar 2022
Colfax Announces Board of Directors for Enovis, the Post-Spinoff Medical Technology Company - Yahoo Finance
Thu, 10 Feb 2022
(02/10/22) Colfax: A Spinoff Bet on the Rales Brothers - Moneyshow.com
Fri, 17 Sep 2021
Hedge Fund and Insider Trading News: Ray Dalio, Steve Cohen, Dmitry Balyasny, Mike Rockefeller, EJF Capital ... - Insider Monkey
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NYSE
|
|
Sector:
Industrials
|
|
Industry:
Specialty Industrial Machinery
|
|
Shares Out | 155 (M) |
Shares Float | 138 (M) |
Held by Insiders | 11.1 (%) |
Held by Institutions | 97.5 (%) |
Shares Short | 8,670 (K) |
Shares Short P.Month | 8,130 (K) |
EPS | 0.7 |
EPS Est Next Qtrly | 0.51 |
EPS Est This Year | 1.72 |
EPS Est Next Year | 1.96 |
Book Value (p.s.) | 29.62 |
Profit Margin | 2.9 % |
Operating Margin | 8.7 % |
Return on Assets (ttm) | 2.6 % |
Return on Equity (ttm) | 3.1 % |
Qtrly Rev. Growth | 19.7 % |
Gross Profit (p.s.) | 8.33 |
Sales Per Share | 23.64 |
EBITDA (p.s.) | 3.74 |
Qtrly Earnings Growth | 65.5 % |
Operating Cash Flow | 389 (M) |
Levered Free Cash Flow | 210 (M) |
PE Ratio | 55.01 |
PEG Ratio | 0.8 |
Price to Book value | 1.31 |
Price to Sales | 1.65 |
Price to Cash Flow | 15.55 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |